Market Place
Sourcing Support
Siegfried opens global R&D Center for Drug Substance in Switzerland
22 Nov 2024 //
INDPHARMAPOST
Dinamiqs opens new lab in Zurich
12 Nov 2024 //
PRESS RELEASE
Strategy EVOLVE+ paves the way for continued profitable growth
24 Oct 2024 //
PRESS RELEASE
EGS Beteiligungen Ups Stake In Siegfried To 7.2% Registered Shares
04 Sep 2024 //
PRESS RELEASE
Siegfried opens new quality control lab in Minden
22 Aug 2024 //
PRESS RELEASE
Marcel Imwinkelried appointed as new CEO
10 Jul 2024 //
PRESS RELEASE
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)
02 Jul 2024 //
PRESS RELEASE
EGS`s sexercises right to convert bond & increases its shareholding Siegfried
14 Jun 2024 //
PRESS RELEASE
Siegfried expands US reach with deal for Wisconsin facility
13 Jun 2024 //
FIERCE PHARMA
Siegfried to acquire an early-phase CDMO in (US) for its Drug Sub services
12 Jun 2024 //
PRESS RELEASE
Siegfried increases distribution to the shareholders & all proposals of the BOD
15 Apr 2024 //
PRESS RELEASE
Changes in Siegfried’s Management Team
02 Apr 2024 //
PRESS RELEASE
Lonza names Siegfried Holding boss as new CEO
02 Apr 2024 //
REUTERS
Enforcement Report - Week of December 20, 2023
20 Dec 2023 //
FDA
Changes in Siegfried’s Executive Committee
15 May 2023 //
PRESS RELEASE
Siegfried acquires stake in DiNAMIQS to establish organization for gene therapies
04 May 2023 //
PRESS RELEASE
Siegfried begins construction of a R&D Center for Drug Substances in Evionnaz
25 Apr 2023 //
PRESS RELEASE
Siegfried increases distribution and appoints new board member
20 Apr 2023 //
PRESS RELEASE
Siegfried opens global Development Center for Drug Products in Barcelona
09 Mar 2023 //
PRESS RELEASE
Siegfried significantly increases sales and profits in 2022
22 Feb 2023 //
PRESS RELEASE
Siegfried appoints Christian Dowdeswell as CBO Drug Substances
06 Feb 2023 //
PRESS RELEASE
Siegfried Announces Change in its Board of Directors
29 Sep 2022 //
PRESS RELEASE
Siegfried and Novavax extend their collaboration
28 Sep 2022 //
PRESS RELEASE
Siegfried begins construction of new large-scale production plant in Minden (DE)
24 Aug 2022 //
PRESS RELEASE
Siegfried increases sales and profits in the first half of 2022
18 Aug 2022 //
PRESS RELEASE
Siegfried Increases Distribution and Appoints Two New Board Members
13 Apr 2022 //
PRESS RELEASE
For the first time, Siegfried reports sales of more one billion Swiss francs
23 Feb 2022 //
PRESS RELEASE
Siegfried Announces Changes in its Board of Directors
20 Dec 2021 //
PRESS RELEASE
Siegfried is included in the Dow Jones Sustainability Index Europe
17 Nov 2021 //
PRESS RELEASE
Siegfried supports Novavax with commercial aseptic fill & finish NVX-CoV2373
04 May 2021 //
PRESS RELEASE
Siegfried Successfully Completes Acquisition of Novartis MFG Sites in Spain
04 Jan 2021 //
PRESS RELEASE
CStone, Pfizer Enter Antibody Alliance
30 Sep 2020 //
CONTRACT PHARMA
Keryx hires Siegfried to make Auryxia API
05 Jan 2018 //
IN PHARMATECHNOLOGIST
Siegfried saw API revs slide in 1H, but earnings up on synergies
31 Aug 2017 //
IN PHARMATECHNOLOGIST
Swiss Generic Manufacturer Siegfried Increased Sales And EBITDA
20 Mar 2017 //
SEEKINGALPHA
Siegfried’s revenues up on APIs and new plants, earnings down on costs
14 Mar 2017 //
IN PHARMATECHNOLOGIST
Swiss firm sees revs soar and says new API biz will drive growth
23 Mar 2016 //
IN PHARMATECHNOLOGIST
Siegfried and BASF reflect on recent API deal
08 Mar 2016 //
IN PHARMATECHNOLOGIST
Siegfried buys BASF drug ingredient businesses for $306 million
07 May 2015 //
REUTERS
